Serveur d'exploration sur la visibilité du Havre

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Hair and fingernail gadolinium ICP-MS contents in an overdose case associated with nephrogenic systemic fibrosis.

Identifieur interne : 000258 ( PubMed/Curation ); précédent : 000257; suivant : 000259

Hair and fingernail gadolinium ICP-MS contents in an overdose case associated with nephrogenic systemic fibrosis.

Auteurs : E. Saussereau [France] ; C. Lacroix ; A. Cattaneo ; L. Mahieu ; J P Goulle

Source :

RBID : pubmed:17983714

English descriptors

Abstract

Nephrogenic systemic fibrosis (NSF) is a rare acquired disorder affecting renal insufficiency patients. There is a growing recognition of the association between the rapid rise in the use of gadolinium (Gd)-containing contrast agents for magnetic resonance imaging (MRI), and the occurrence of acute nephrogenic systemic fibrosis. This case report concerns a 62-year-old woman with chronic renal insufficiency who underwent numerous MRI examinations using Gd-based contrast agents. For the first time, to our knowledge, Gd was performed in the NSF patient's blood, as well as in hair and in fingernails by inductively plasma coupled mass spectrometry. Gd contents in blood, hair and in fingernails were initially 300 to 1000 times higher compared to controls. These results are a new illustration of the strong association between the frequent use of Gd-based contrast media and NSF in patients with kidney diseases. Gd quantitative determination could be of major interest for patients with renal failure who are required to undergo repeated gadolinium-enhanced MRI examinations.

DOI: 10.1016/j.forsciint.2007.06.026
PubMed: 17983714

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:17983714

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Hair and fingernail gadolinium ICP-MS contents in an overdose case associated with nephrogenic systemic fibrosis.</title>
<author>
<name sortKey="Saussereau, E" sort="Saussereau, E" uniqKey="Saussereau E" first="E" last="Saussereau">E. Saussereau</name>
<affiliation wicri:level="1">
<nlm:affiliation>Pharmacokinetic and Toxicology Laboratory, J. Monod Hospital, F-76083 Le Havre Cedex, France. esaussereau@ch-havre.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Pharmacokinetic and Toxicology Laboratory, J. Monod Hospital, F-76083 Le Havre Cedex</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Lacroix, C" sort="Lacroix, C" uniqKey="Lacroix C" first="C" last="Lacroix">C. Lacroix</name>
</author>
<author>
<name sortKey="Cattaneo, A" sort="Cattaneo, A" uniqKey="Cattaneo A" first="A" last="Cattaneo">A. Cattaneo</name>
</author>
<author>
<name sortKey="Mahieu, L" sort="Mahieu, L" uniqKey="Mahieu L" first="L" last="Mahieu">L. Mahieu</name>
</author>
<author>
<name sortKey="Goulle, J P" sort="Goulle, J P" uniqKey="Goulle J" first="J P" last="Goulle">J P Goulle</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="RBID">pubmed:17983714</idno>
<idno type="pmid">17983714</idno>
<idno type="doi">10.1016/j.forsciint.2007.06.026</idno>
<idno type="wicri:Area/PubMed/Corpus">000258</idno>
<idno type="wicri:Area/PubMed/Curation">000258</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Hair and fingernail gadolinium ICP-MS contents in an overdose case associated with nephrogenic systemic fibrosis.</title>
<author>
<name sortKey="Saussereau, E" sort="Saussereau, E" uniqKey="Saussereau E" first="E" last="Saussereau">E. Saussereau</name>
<affiliation wicri:level="1">
<nlm:affiliation>Pharmacokinetic and Toxicology Laboratory, J. Monod Hospital, F-76083 Le Havre Cedex, France. esaussereau@ch-havre.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Pharmacokinetic and Toxicology Laboratory, J. Monod Hospital, F-76083 Le Havre Cedex</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Lacroix, C" sort="Lacroix, C" uniqKey="Lacroix C" first="C" last="Lacroix">C. Lacroix</name>
</author>
<author>
<name sortKey="Cattaneo, A" sort="Cattaneo, A" uniqKey="Cattaneo A" first="A" last="Cattaneo">A. Cattaneo</name>
</author>
<author>
<name sortKey="Mahieu, L" sort="Mahieu, L" uniqKey="Mahieu L" first="L" last="Mahieu">L. Mahieu</name>
</author>
<author>
<name sortKey="Goulle, J P" sort="Goulle, J P" uniqKey="Goulle J" first="J P" last="Goulle">J P Goulle</name>
</author>
</analytic>
<series>
<title level="j">Forensic science international</title>
<idno type="eISSN">1872-6283</idno>
<imprint>
<date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Contrast Media (adverse effects)</term>
<term>Contrast Media (analysis)</term>
<term>Drug Overdose</term>
<term>Female</term>
<term>Fibrosis</term>
<term>Gadolinium DTPA (adverse effects)</term>
<term>Gadolinium DTPA (analysis)</term>
<term>Hair (chemistry)</term>
<term>Half-Life</term>
<term>Humans</term>
<term>Kidney Failure, Chronic (complications)</term>
<term>Magnetic Resonance Imaging</term>
<term>Meglumine (adverse effects)</term>
<term>Meglumine (analysis)</term>
<term>Middle Aged</term>
<term>Nails (chemistry)</term>
<term>Organometallic Compounds (adverse effects)</term>
<term>Organometallic Compounds (analysis)</term>
<term>Skin (pathology)</term>
<term>Skin Diseases (chemically induced)</term>
<term>Spectrophotometry, Atomic</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Contrast Media</term>
<term>Gadolinium DTPA</term>
<term>Meglumine</term>
<term>Organometallic Compounds</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Contrast Media</term>
<term>Gadolinium DTPA</term>
<term>Meglumine</term>
<term>Organometallic Compounds</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en">
<term>Skin Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en">
<term>Hair</term>
<term>Nails</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Kidney Failure, Chronic</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Skin</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Drug Overdose</term>
<term>Female</term>
<term>Fibrosis</term>
<term>Half-Life</term>
<term>Humans</term>
<term>Magnetic Resonance Imaging</term>
<term>Middle Aged</term>
<term>Spectrophotometry, Atomic</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Nephrogenic systemic fibrosis (NSF) is a rare acquired disorder affecting renal insufficiency patients. There is a growing recognition of the association between the rapid rise in the use of gadolinium (Gd)-containing contrast agents for magnetic resonance imaging (MRI), and the occurrence of acute nephrogenic systemic fibrosis. This case report concerns a 62-year-old woman with chronic renal insufficiency who underwent numerous MRI examinations using Gd-based contrast agents. For the first time, to our knowledge, Gd was performed in the NSF patient's blood, as well as in hair and in fingernails by inductively plasma coupled mass spectrometry. Gd contents in blood, hair and in fingernails were initially 300 to 1000 times higher compared to controls. These results are a new illustration of the strong association between the frequent use of Gd-based contrast media and NSF in patients with kidney diseases. Gd quantitative determination could be of major interest for patients with renal failure who are required to undergo repeated gadolinium-enhanced MRI examinations.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">17983714</PMID>
<DateCreated>
<Year>2008</Year>
<Month>2</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted>
<Year>2008</Year>
<Month>04</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised>
<Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1872-6283</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>176</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2008</Year>
<Month>Mar</Month>
<Day>21</Day>
</PubDate>
</JournalIssue>
<Title>Forensic science international</Title>
<ISOAbbreviation>Forensic Sci. Int.</ISOAbbreviation>
</Journal>
<ArticleTitle>Hair and fingernail gadolinium ICP-MS contents in an overdose case associated with nephrogenic systemic fibrosis.</ArticleTitle>
<Pagination>
<MedlinePgn>54-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Nephrogenic systemic fibrosis (NSF) is a rare acquired disorder affecting renal insufficiency patients. There is a growing recognition of the association between the rapid rise in the use of gadolinium (Gd)-containing contrast agents for magnetic resonance imaging (MRI), and the occurrence of acute nephrogenic systemic fibrosis. This case report concerns a 62-year-old woman with chronic renal insufficiency who underwent numerous MRI examinations using Gd-based contrast agents. For the first time, to our knowledge, Gd was performed in the NSF patient's blood, as well as in hair and in fingernails by inductively plasma coupled mass spectrometry. Gd contents in blood, hair and in fingernails were initially 300 to 1000 times higher compared to controls. These results are a new illustration of the strong association between the frequent use of Gd-based contrast media and NSF in patients with kidney diseases. Gd quantitative determination could be of major interest for patients with renal failure who are required to undergo repeated gadolinium-enhanced MRI examinations.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Saussereau</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Pharmacokinetic and Toxicology Laboratory, J. Monod Hospital, F-76083 Le Havre Cedex, France. esaussereau@ch-havre.fr</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lacroix</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cattaneo</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mahieu</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Goulle</LastName>
<ForeName>J P</ForeName>
<Initials>JP</Initials>
</Author>
</AuthorList>
<Language>ENG</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2007</Year>
<Month>Nov</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Ireland</Country>
<MedlineTA>Forensic Sci Int</MedlineTA>
<NlmUniqueID>7902034</NlmUniqueID>
<ISSNLinking>0379-0738</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009942">Organometallic Compounds</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C072417">gadoterate meglumine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>6HG8UB2MUY</RegistryNumber>
<NameOfSubstance UI="D008536">Meglumine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>K2I13DR72L</RegistryNumber>
<NameOfSubstance UI="D019786">Gadolinium DTPA</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D003287" MajorTopicYN="N">Contrast Media</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D062787" MajorTopicYN="N">Drug Overdose</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019786" MajorTopicYN="N">Gadolinium DTPA</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006197" MajorTopicYN="N">Hair</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006207" MajorTopicYN="N">Half-Life</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007676" MajorTopicYN="N">Kidney Failure, Chronic</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008536" MajorTopicYN="N">Meglumine</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009262" MajorTopicYN="N">Nails</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009942" MajorTopicYN="N">Organometallic Compounds</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012871" MajorTopicYN="N">Skin Diseases</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013054" MajorTopicYN="N">Spectrophotometry, Atomic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2007</Year>
<Month>5</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2007</Year>
<Month>6</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2007</Year>
<Month>11</Month>
<Day>7</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2008</Year>
<Month>4</Month>
<Day>11</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2007</Year>
<Month>11</Month>
<Day>7</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">17983714</ArticleId>
<ArticleId IdType="pii">S0379-0738(07)00758-X</ArticleId>
<ArticleId IdType="doi">10.1016/j.forsciint.2007.06.026</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/France/explor/LeHavreV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000258 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000258 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/France
   |area=    LeHavreV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:17983714
   |texte=   Hair and fingernail gadolinium ICP-MS contents in an overdose case associated with nephrogenic systemic fibrosis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:17983714" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LeHavreV1 

Wicri

This area was generated with Dilib version V0.6.25.
Data generation: Sat Dec 3 14:37:02 2016. Site generation: Tue Mar 5 08:25:07 2024